Hematologic Malignancies Grand Rounds: Targeting Sphingosine Kinase 2 in Multiple Myeloma.

Hematologic Malignancies Grand Rounds is a weekly teaching conference for hematologic malignancies providers to be able to utilize multidisciplinary methods to keep up with the most current treatment guidelines and changing standards of care for their patients.